The Crosstalk Between the Matrix Metalloprotease System and the Chemokine Network in Acute Myeloid Leukemia
Keywords: 2-macroglobulin; Acute myelogenous leukemia; Matrix metalloproteinases (MMPs); Thrombospondin-1; acute myeloid leukemia (AML); all-trans retinoic acid; angiogenesis; anthracyclines; antiapoptotic signaling; autocrine manner; bone marrow microenvironment; chemokines; chemosensitivity; chemotactic cytokines; collagenases; cysteine-zinc interaction; cytotoxic agents; extracellular matrix (ECM); fibroblast growth factor (bFGF); gelatinases; hematologic malignancies; hematopoiesis; hematopoietic development; hematopoietic stem cells; hemorrhages; hyaluronan receptor; leukemogenesis; lipoprotein; matrilysins; matrix metalloproteases; mesenchymal cells; mitogen activated protein kinases (MAPK); myeloid cells; nuclear factor-B (NF-B); plasminogen; stromelysins; tissue inhibitor of MMPs; tissue inhibitors of matrix metalloproteases; transmembrane glycoprotein; tumor necrosis factor(TNF); vascular endothelial growth factor (VEGF)
Document Type: Research Article
Publication date: 2010-12-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.